Home/ Supplements/ Niacin/ JetFuel Original

JetFuel Original

product on market Capsule GAT Sport Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Niacin and Vitamin B12 support energy metabolism, while Bioperine is moderately evidenced to enhance nutrient absorption. The thermogenic blend typically targets metabolic rate, though specific evidence for this proprietary mix is limited. Overall, the ingredient profile focuses on energy production and metabolic support.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for JetFuel Original
Open Full PDF View on NIH DSLD →
Details

Label Data

3 Oil-Infused Capsule(s)
Serving Size
48
Servings
Other Combinations
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

25.5 mg (159% DV)
1.8× RDA — within safe limits 196 studies (A:5, B:63)
360 mcg (15000% DV)
150.0× RDA — above typical dose 139 studies (A:1, B:44)
Jetfuel Concentrated Thermogenic Blend
961.74 mg
Bioperine
5 mg

Other Ingredients

Rice Flour Gelatin Maltodextrin Natural & Artificial Flavors
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Warnings & Precautions

Contains: Soy.

Each serving contains approx. 200 mg of caffeine.

Formulation Notes

Premium cutting & thermogenic compound Lasting energy support & appetite control Powerful fat metabolizer

No sugar, artificial preservatives or colors.

Each serving contains approx. 200 mg of caffeine.

Additional Information

JetFuel 15 years strong!

GAT Authentic Satisfaction Guaranteed

Metadata

Product Details

DSLD Entry Date2025-08-22
Product TypeOther Combinations
FormCapsule
DSLD ID339365
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

View all Niacin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.